Performance of LLY Eli Lilly and Company | 52.6% in 12m
Compare LLY with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Eli Lilly and Company with its related Sector/Index XLV
Performance Duell LLY vs XLV
| TimeFrame | LLY | XLV |
|---|---|---|
| 1 Week | -5.63% | -1.88% |
| 1 Month | 6.94% | 3.16% |
| 3 Months | 6.35% | 5.55% |
| 6 Months | 18.8% | 5.93% |
| 12 Months | 52.6% | 17.65% |
| YTD | 53.2% | 11.77% |
| Rel. Perf. 1m | 1.09 | |
| Rel. Perf. 3m | 1.23 | |
| Rel. Perf. 6m | 1.37 | |
| Rel. Perf. 12m | 1.37 | |
| Spearman 1m | 0.49 | 0.82 |
| Spearman 3m | 0.37 | 0.89 |
Is Eli Lilly and Company a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Eli Lilly and Company (NYSE:LLY) is currently (September 2024)
ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 46.45 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LLY as of September 2024 is 1255.68. This means that LLY is currently undervalued and has a potential upside of +39.1% (Margin of Safety).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LLY as of September 2024 is 1255.68. This means that LLY is currently undervalued and has a potential upside of +39.1% (Margin of Safety).
Is LLY a buy, sell or hold?
- Strong Buy: 17
- Buy: 6
- Hold: 4
- Sell: 1
- Strong Sell: 0
Values above 0%: LLY is performing better - Values below 0%: LLY is underperforming
Compare LLY with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -3.51% | 5.11% | 12.54% | 30.41% |
| US NASDAQ 100 | QQQ | -2.79% | 6.80% | 16.31% | 32.74% |
| US Dow Jones Industrial 30 | DIA | -4.22% | 4.34% | 13.73% | 34.09% |
| German DAX 40 | DBXD | -2.26% | 3.43% | 16.53% | 37.99% |
| UK FTSE 100 | ISFU | -3.44% | 2.70% | 7.57% | 34.43% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -4.55% | 9.50% | 24.81% | 63.50% |
| Hongkong Hang Seng | HSI | -5.69% | 5.27% | 18.98% | 58.43% |
| Japan Nikkei 225 | EXX7 | 0.71% | 5.92% | 27.19% | 46.73% |
| India NIFTY 50 | INDA | -4.29% | 5.61% | 10.72% | 28.28% |
| Brasil Bovespa | EWZ | -5.56% | 3.60% | 25.00% | 52.35% |
LLY Eli Lilly and Company vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -3.36% | 7.79% | 12.99% | 28.07% |
| Consumer Discretionary | XLY | -4.47% | 1.97% | 17.21% | 46.50% |
| Consumer Staples | XLP | -5.51% | 1.93% | 6.74% | 34.44% |
| Energy | XLE | -2.26% | 10.53% | 19.68% | 54.73% |
| Financial | XLF | -3.19% | 2.04% | 8.93% | 21.85% |
| Health Care | XLV | -3.75% | 3.78% | 12.88% | 34.94% |
| Industrial | XLI | -3.56% | 5.63% | 15.20% | 31.52% |
| Materials | XLB | -3.19% | 5.52% | 17.36% | 40.94% |
| Real Estate | XLRE | -5.58% | 2.06% | 8.35% | 29.22% |
| Technology | XLK | -2.64% | 7.33% | 20.13% | 34.27% |
| Utilities | XLU | -5.28% | 3.46% | -2.22% | 28.83% |
| Aerospace & Defense | XAR | -3.35% | 5.95% | 14.01% | 26.25% |
| Biotech | XBI | -3.46% | 5.34% | 21.14% | 29.98% |
| Homebuilder | XHB | -4.59% | 2.63% | 11.36% | 14.99% |
| Retail | XRT | -2.27% | 8.17% | 22.24% | 33.94% |
Does Eli Lilly and Company outperform its market, is LLY a Sector Leader?
Yes, over the last 12 months Eli Lilly and Company (LLY) made 52.59%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 17.65%.
Over the last 3 months LLY made 6.35%, while XLV made 5.55%.
Yes, over the last 12 months Eli Lilly and Company (LLY) made 52.59%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 17.65%.
Over the last 3 months LLY made 6.35%, while XLV made 5.55%.
| Period | LLY | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 6.94% | 3.16% | 1.83% |
| 3 Months | 6.35% | 5.55% | 1.52% |
| 12 Months | 52.59% | 17.65% | 22.18% |